| Bioactivity | Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1. | ||||||||||||
| Target | Target: LXR | ||||||||||||
| Invitro | Rovazolac is an anti-inflammatory drug candidate[1]. | ||||||||||||
| Name | Rovazolac | ||||||||||||
| CAS | 1454288-88-0 | ||||||||||||
| Formula | C21H19F3N2O4S | ||||||||||||
| Molar Mass | 452.45 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1 |